Skip to main navigation Skip to search Skip to main content

Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)

  • Johannes Hofland
  • , Angela Lamarca
  • , the ENETS Carcinoid Heart Disease Task Force
  • , Richard Steeds
  • , Christos Toumpanakis
  • , Rajaventhan Srirajaskanthan
  • , Rachel Riechelmann
  • , Francesco Panzuto
  • , Andrea Frilling
  • , Timm Denecke
  • , Emanuel Christ
  • , Simona Grozinsky-Glasberg
  • , Joseph Davar*
  • *Corresponding author for this work
  • University of Manchester and Christie NHS Foundation Trust
  • University of Manchester
  • University Hospitals Birmingham NHS Foundation Trust
  • Royal Free London NHS Foundation Trust
  • King’s College Hospital
  • Sant'Andrea Hospital
  • Imperial College London
  • University Hospital Leipzig
  • Universitätsspital Basel
  • Hebrew University of Jerusalem
  • University of Birmingham
  • A.C. Camargo Cancer Centre
  • Hadassah University Medical Centre
  • University College London

Research output: Contribution to journalArticleAcademicpeer-review

32 Citations (Scopus)
143 Downloads (Pure)

Abstract

Background: This European Neuroendocrine Tumor Society (ENETS) Expert Consensus document aims to provide practical guidance and standardization for echocardiography in the screening and follow-up of carcinoid heart disease (CHD) in patients with a neuroendocrine tumour (NET) and carcinoid syndrome. Methods: NET experts within the ENETS Carcinoid Heart Disease Task Force reviewed both general reporting guidelines and specialized scoring systems for transthoracic echocardiography (TTE) in CHD. Based on this review, a dedicated template report was designed by the multidisciplinary working group of cardiologists, oncologists, endocrinologists, gastroenterologists, surgeons and radiologists. Results: We propose a Synoptic Reporting of Echocardiography in Carcinoid Heart Disease which represents an agreed peer reviewed proforma to capture information at the time of referral and enable a detailed outcome of CHD assessment. This includes a systematic and detailed list of structures to evaluate data to capture at the time of reporting of TTE. Conclusions: Adherence to these reporting guidelines aims to promote homogeneous and detailed evaluation of CHD to secure accurate assessment and allow comparison of studies performed intra- and inter-individually. These guidelines could also facilitate CHD assessment as part of prospective clinical trials to enable standardization of the findings seen in response to therapy.

Original languageEnglish
Article numbere13060
JournalJournal of Neuroendocrinology
Volume34
Issue number3
Early online date2 Nov 2021
DOIs
Publication statusPublished - Mar 2022

Bibliographical note

Funding Information: Dr Angela Lamarca is part funded by The Christie Charity.

Publisher Copyright: © 2021 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)'. Together they form a unique fingerprint.

Cite this